Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | TDO2 | P48775 | 2/20 | 0.42 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11621775 | 0.92 | ADRB2 (0.52) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL2865480 | 0.87 | ADRB2 (0.41) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL30471741 | 0.85 | TYR (0.46) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL8750387 | 0.85 | TYR (0.46) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL197810 | 0.81 | ADRB2 (0.65) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL1045498 | 0.80 | ADRB2 (0.56) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL30720007 | 0.79 | ADRB2 (0.62) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL4445207 | 0.79 | ADRB2 (0.62) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| SCHEMBL153358 | 0.79 | ADRB2 (0.62) | ADRB2TSHRHIF1AMAPK1TDP1 | |
| Hydrochloric Acid SCHEMBL28767407 | 0.79 | ADRB2 (0.62) | ADRB2TSHRHIF1AMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11171804-A | — | — | None | — | — | JP | disclosed |
| CN-122059820-A | Method for synthesizing carboxylic acid compound by titanium catalysis | 陕西师范大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-122059950-A | Compounds with proteasome agonistic activity, preparation method and application thereof | 浙大城市学院 | 2026-05-19 | — | — | CN | disclosed |
| US-20230022091-A1 | COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2023-01-26 | — | — | US | disclosed |
| US-11466034-B2 | Compound functioning as bromodomain protein inhibitor, and composition | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2022-10-11 | — | — | US | disclosed |
| CN-115160101-A | Synthetic method of (R) -1, 3-diaryl butene compound | 南京工业大学 | 2022-10-11 | — | — | CN | disclosed |
| US-20200385408-A1 | COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2020-12-10 | — | — | US | disclosed |
| CN-107721886-B | Preparation method of 1-aryl ethanesulfonic acid and derivatives thereof | 河南新天地药业股份有限公司 | 2020-11-03 | — | — | CN | disclosed |
| EP-3719017-A2 | COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION | Betta Pharmaceuticals Co., Ltd. (CN) | 2020-10-07 | — | — | EP | disclosed |
| CN-110802101-A | Method for manufacturing mould by recovering all components of wind power blade through two-step method | 中国科学院山西煤炭化学研究所 | 2020-02-18 | — | — | CN | disclosed |
| EP-0705258-A1 | AZOLYL-CYCLIC AMINE DERIVATIVES WITH IMMUNOMODULATORY ACTIVITY | Knoll AG (DE) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995000507-A1 | AZOLYL-CYCLIC AMINE DERIVATIVES WITH IMMUNOMODULATORY ACTIVITY | KNOLL AG (DE) | 1995-01-05 | — | — | WO | disclosed |
| US-4156602-A | 1-(1-Chloropropyl)-2,4,6-triisopropylbenzene and its use to control weeds | PPG INDUSTRIES, INC. (US) | 1979-05-29 | — | — | US | disclosed |
| EP-0000019-A1 | N-benzylcycloalkylamines and process for their preparation | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1978-12-20 | — | — | EP | disclosed |
| US-4081596-A | DIURETIC, SALURETIC, ANTIHYPERTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-28 | — | — | US | disclosed |
| US-4019893-A | Herbicidal method using 2-sulfinyl or 2-sulfonyl pyridine N-oxide derivatives | UNIROYAL INC. (US) | 1977-04-26 | — | — | US | disclosed |
| US-4005215-A | DIURETIC | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-25 | — | — | US | disclosed |
| US-3978077-A | DIURETIC, HYPOTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (GB) | 1976-08-31 | — | — | US | disclosed |
| US-3960542-A | Herbicidal 2-sulfinyl and 2-sulfonyl pyridine N-oxide derivatives | UNIROYAL INC. (US) | 1976-06-01 | — | — | US | disclosed |
| US-3957814-A | DIURETICS, SALURETICS, HYPOTENSIVE AGENTS, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11466034-B2 | Compound functioning as bromodomain protein inhibitor, and composition | BRD4, BRD1, BRD2 | ADRB2 3998/4885TSHR 4320/4885HIF1A 4414/4885 |
| US-20230022091-A1 | COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION | BRD4, BRD1, BRD2 | ADRB2 3998/4885TSHR 4320/4885HIF1A 4414/4885 |
| US-20200385408-A1 | COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION | BRD4, BRD1, BRD2 | ADRB2 3998/4885TSHR 4320/4885HIF1A 4414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.